Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02467179 · ClinicalTrials.gov registry record · NA
Evaluation of the Amigo Robotic System for Ablation of the Cavo-Tricuspid Isthmus
A NA study, sponsored by University of California, San Diego.
- Completed
- Registry status
- NA
- Development phase
- 50
- Enrollment target
NCT02467179 is a NA study that has completed, run by University of California, San Diego. The registered enrollment target is 50 participants.
The verdict
NCT02467179, a NA study, has completed, sponsored by University of California, San Diego.
- COMPLETED
- Registry status
- NA
- Development phase
- 50 participants
- Enrollment target
Study Summary
The purpose of this study is to compare standard manual and robotically controlled catheter ablation of the cavo-tricuspid isthmus (CTI) as a treatment for atrial flutter. Ablation of the CTI is standard treatment for patients with a history of atrial flutter, and those undergoing ablation for atrial fibrillation. Both manual and robotic catheter manipulation are used in standard clinical practice at The University of California, San Diego (UCSD) for ablation.
Interventions
- DEVICE Amigo™ Robotic Catheter Manipulation
- DEVICE Manual Catheter Manipulation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2015-03 |
| Est. Completion | 2018-03-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02467179
The ClinicalTrials.gov registry entry for NCT02467179 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, San Diego, which has 775 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Amigo™ Robotic Catheter Manipulation is the first listed.
NCT02467179 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02467179 about?
NCT02467179 is a clinical study titled "Evaluation of the Amigo Robotic System for Ablation of the Cavo-Tricuspid Isthmus". The purpose of this study is to compare standard manual and robotically controlled catheter ablation of the cavo-tricuspid isthmus (CTI) as a treatment for atrial flutter. Ablation of the CTI is standard treatment for patients with a history of atrial flutter, and those undergoing ablation for atria...
What is the current status of trial NCT02467179?
This trial is currently completed. It is a NA study. The enrollment target is 50 participants. The study started on 2015-03. Estimated completion is 2018-03-30.
What interventions are being tested in trial NCT02467179?
The interventions under investigation include: Amigo™ Robotic Catheter Manipulation (DEVICE), Manual Catheter Manipulation (DEVICE).
Who is sponsoring clinical trial NCT02467179?
This trial is sponsored by University of California, San Diego, which has 775 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.